These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 30504350)

  • 1. New insights into the pathophysiology and development of novel therapies for sickle cell disease.
    Moerdler S; Manwani D
    Hematology Am Soc Hematol Educ Program; 2018 Nov; 2018(1):493-506. PubMed ID: 30504350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Sickle Cell Disease Therapies: Targeting Pathways Downstream of Sickling.
    Morrone K; Mitchell WB; Manwani D
    Semin Hematol; 2018 Apr; 55(2):68-75. PubMed ID: 30616808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sickle red cell microrheology and sickle blood rheology.
    Ballas SK; Mohandas N
    Microcirculation; 2004 Mar; 11(2):209-25. PubMed ID: 15280093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion.
    Frenette PS
    Microcirculation; 2004 Mar; 11(2):167-77. PubMed ID: 15280090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology.
    Zhang D; Xu C; Manwani D; Frenette PS
    Blood; 2016 Feb; 127(7):801-9. PubMed ID: 26758915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolving treatment paradigms in sickle cell disease.
    Jagadeeswaran R; Rivers A
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):440-446. PubMed ID: 29222291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin.
    Falanga A; Trinchero A
    Haematologica; 2013 Jul; 98(7):995-7. PubMed ID: 23813643
    [No Abstract]   [Full Text] [Related]  

  • 8. Sickle red cell-endothelium interactions.
    Kaul DK; Finnegan E; Barabino GA
    Microcirculation; 2009 Jan; 16(1):97-111. PubMed ID: 18720225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and treatment of sickle cell disease.
    Raphael RI
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):492-505. PubMed ID: 16167028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endothelial biology of sickle cell disease: inflammation and a chronic vasculopathy.
    Hebbel RP; Osarogiagbon R; Kaul D
    Microcirculation; 2004 Mar; 11(2):129-51. PubMed ID: 15280088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythrocyte membrane sulfatide plays a crucial role in the adhesion of sickle erythrocytes to endothelium.
    Zhou Z; Thiagarajan P; Udden M; Lòpez JA; Guchhait P
    Thromb Haemost; 2011 Jun; 105(6):1046-52. PubMed ID: 21437360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor H interferes with the adhesion of sickle red cells to vascular endothelium: a novel disease-modulating molecule.
    Lombardi E; Matte A; Risitano AM; Ricklin D; Lambris JD; De Zanet D; Jokiranta ST; Martinelli N; Scambi C; Salvagno G; Bisoffi Z; Colato C; Siciliano A; Bortolami O; Mazzuccato M; Zorzi F; De Marco L; De Franceschi L
    Haematologica; 2019 May; 104(5):919-928. PubMed ID: 30630982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intercellular adhesion molecule-4 and CD36 are implicated in the abnormal adhesiveness of sickle cell SAD mouse erythrocytes to endothelium.
    Trinh-Trang-Tan MM; Vilela-Lamego C; Picot J; Wautier MP; Cartron JP
    Haematologica; 2010 May; 95(5):730-7. PubMed ID: 20015873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombosis and sickle cell disease.
    De Franceschi L; Cappellini MD; Olivieri O
    Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Not all red cells sickle the same: Contributions of the reticulocyte to disease pathology in sickle cell anemia.
    Carden MA; Fasano RM; Meier ER
    Blood Rev; 2020 Mar; 40():100637. PubMed ID: 31735458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheological and adherence properties of sickle cells. Potential contribution to hematologic manifestations of the disease.
    Mohandas N; Evans E
    Ann N Y Acad Sci; 1989; 565():327-37. PubMed ID: 2672968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of plasma-mediated adherence of sickle erythrocytes to microvascular endothelium by conformationally constrained RGD-containing peptides.
    Kumar A; Eckman JR; Wick TM
    Am J Hematol; 1996 Oct; 53(2):92-8. PubMed ID: 8892733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo studies of sickle red blood cells.
    Kaul DK; Fabry ME
    Microcirculation; 2004 Mar; 11(2):153-65. PubMed ID: 15280089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of sickle erythrocyte adherence to endothelium by autologous platelets.
    Antonucci R; Walker R; Herion J; Orringer E
    Am J Hematol; 1990 May; 34(1):44-8. PubMed ID: 2109530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion of sickle red blood cells and damage to interleukin-1 beta stimulated endothelial cells under flow in vitro.
    Natarajan M; Udden MM; McIntire LV
    Blood; 1996 Jun; 87(11):4845-52. PubMed ID: 8639858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.